Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GSK Expects To Restore Avandia Inventory Before Avandamet

This article was originally published in The Pink Sheet Daily

Executive Summary

GlaxoSmithKline says supplies of Coreg have returned to normal levels following a shortage at the end of 2005.

You may also be interested in...



Avandamet Supply Issues Are Resolved, Allowing Launch Of New Indication

GlaxoSmithKline's announcement about renewed Avandamet availability follows the approval of the type 2 diabetes drug for first-line use.

Avandamet Supply Issues Are Resolved, Allowing Launch Of New Indication

GlaxoSmithKline's announcement about renewed Avandamet availability follows the approval of the type 2 diabetes drug for first-line use.

Avandamet sNDA Approved For First-Line Use In Type 2 Diabetics

GlaxoSmithKline’s updated label for the rosiglitazone/metformin combination also includes new data concerning risk in congestive heart failure patients.

Related Content

Topics

UsernamePublicRestriction

Register

PS064264

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel